Health

  • April 28, 2026

    Chinese Man Extradited From Italy Over COVID Data Theft

    A Chinese citizen has appeared before a Houston federal court after being extradited from Italy to face charges for his alleged role in the Microsoft "HAFNIUM" cyberattack that was allegedly orchestrated by the Chinese government to target U.S. COVID-19 research.

  • April 28, 2026

    Nurses Fight 'Deceptive' Opt-Out Push In $14M Wage Deal

    Nurses involved in a $14 million wage-and-hour class settlement are urging a Colorado federal judge to block what they call a misleading opt-out campaign by a named plaintiff in a related action in state court, saying mass texts promising unsubstantiated recoveries threaten to undermine the deal.

  • April 28, 2026

    Maryland Justices Allow IVF Cost Class Action To Proceed

    A Maryland couple can pursue a proposed class action against a health insurer that they say wrongfully denied coverage for embryo thawing in connection with an in vitro fertilization procedure, the Maryland Supreme Court has ruled, finding that the insurer's subsequent payment of the claim doesn't moot the suit.

  • April 28, 2026

    Ga. Parents Say Child's $37M Death Verdict Wrongly Reduced

    A couple whose son died during lymphoma treatment at a university medical center told a Georgia appellate panel Tuesday that a trial court misinterpreted the state's tort claims act when it reduced a verdict in their favor from $37 million to $2 million.

  • April 28, 2026

    Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent

    AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an upfront payment and up to $2.25 billion in additional milestone payments. 

  • April 28, 2026

    Meet The Attys Arguing The High Court 'Skinny Label' Case

    When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.

  • April 28, 2026

    Anti-Pot Group Says CMS Violated APA With Hemp Program

    A group of advocates opposed to legal cannabis, as well as a cannabinoid company and two individuals, are fighting the government's bid to halt their challenge to a program to give Medicare beneficiaries access to federally legal hemp products, saying the Centers for Medicare & Medicaid Services violated federal law by instituting the program without notice or comment.

  • April 27, 2026

    North Dakota Drug-Pricing Law Blocked In Pharma Fight

    A North Dakota federal judge on Monday blocked the state's new drug-pricing law, agreeing with pharmaceutical companies that while the law purports to "protect the underdogs," it illegally interferes with the federal drug-pricing regime.

  • April 27, 2026

    DOJ Says Wash. 340B Drug Law Is Preempted In Novartis Suit

    The U.S. Department of Justice waded into a dispute between pharmaceutical giants and the state of Washington on Monday, arguing that federal law preempts a new state law that expands discounts that drugmakers must provide under the federal 340B Drug Pricing Program.

  • April 27, 2026

    Sullivan & Cromwell Alum Returns After 5 Years With DOJ

    A former Sullivan & Cromwell attorney is returning to the firm after five years in the public sector working for the U.S. Department of Justice's criminal division, where he prosecuted high-profile insider trading cases and secured convictions for two former Merrill Lynch traders accused of manipulating the precious metals market.

  • April 27, 2026

    Wyoming's Latest Near-Total Abortion Ban Blocked

    A Wyoming judge has blocked enforcement of the latest effort by state lawmakers to enact a rigid anti-abortion law, after the Wyoming Supreme Court in January struck down the state's previous near-total ban on abortion. 

  • April 27, 2026

    'General Hospital' Actor Can't Revive Vax Suit Against ABC

    California appellate justices refused to reinstate a "General Hospital" actor's suit alleging ABC fired him for his political views after he declined to comply with its COVID-19 vaccine policy, ruling the evidence shows that the ultimate decision-makers who ended his employment agreement didn't know about his political views.

  • April 27, 2026

    ER Docs Urge Justices To Back 5th Circ. Revival Of BCBS Suit

    Emergency room doctors urged the U.S. Supreme Court on Monday not to disturb a Fifth Circuit decision reviving their insurance reimbursement dispute against Blue Cross Blue Shield involving out-of-network claims from employee benefit plans, arguing the appellate court correctly restarted proceedings in the case.

  • April 27, 2026

    Nursing Home Hit With Wage Suit Over Meal, OT Pay

    Two former caregivers have hit a Michigan assisted living and memory care facility with a proposed collective action, alleging the facility failed to properly pay overtime by requiring hourly employees to work through unpaid meal breaks and excluding bonuses from overtime calculations. 

  • April 27, 2026

    Attys, Advocates Call DOJ Pot Rule Historic Shift For Feds

    Legal strategies are evolving quickly in the wake of last week's "historic" rescheduling of state-legal medical cannabis, as a group of attorneys and advocates gathered Monday to evaluate the trade-offs of dispensaries now being able to register like pharmacies with the feds and the potential effect on industry investments and trade.

  • April 27, 2026

    IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

    IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    Ex-Federal Workers Seek Reinstatement In Md. Federal Court

    The Trump administration disguised ideologically motivated firings as routine layoffs, then pushed workers into a broken system to challenge their discharges, a group of laid-off federal workers alleged, asking a Maryland federal judge to deem the layoffs unconstitutional and reinstate the workers to their former positions.

  • April 27, 2026

    Cannabis Co. Can't Shift Atty AI Sanctions To Rival Company

    A Florida federal judge will not force a medical marijuana company to accept liability for sanctions incurred by its in-house counsel over the misuse of generative artificial intelligence, rejecting a rival company's arguments that the lawyer previously avoided monetary sanctions for filing errors and was likely to do so again.

  • April 27, 2026

    Convicted Pa. Dentist Says Feds Failed To Prove Fraud

    A Pennsylvania dentist convicted along with his brother for using their dental practice to defraud Medicare, install unapproved dental implants in patients, and falsify visas to recruit foreign workers has asked a federal judge for acquittal or a new trial, arguing the government failed to show he committed any crimes.

  • April 27, 2026

    Medical Group Says Secret Call Could Upend Estate's Verdict

    A Connecticut anesthesiology group has asked a state appeals court to reverse its portion of a $20 million wrongful death verdict, saying a lower court judge should have allowed into evidence a secret phone recording of a surgeon, used different verdict forms and blocked testimony from an allegedly unqualified witness.

  • April 27, 2026

    What To Watch As Justices Take On 'Skinny Label' Case

    The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the drug industry that could shape patent disputes more broadly and other legal areas. Here's what to watch for.

  • April 27, 2026

    4th Circ. Says Medicaid Fraud Convictions Lacked Evidence

    The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

    Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.

Expert Analysis

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • CMS Healthcare Enforcement Initiatives May Cause Disruption

    Author Photo

    The Centers for Medicare & Medicaid Services' recently announced enforcement actions against healthcare fraud mark a significant escalation, and CMS' prior approach in the hospice sector suggests that even compliant providers and suppliers should brace for impact, say attorneys at Morgan Lewis.

  • How Cos. Should Prepare For NY RAISE Act Compliance

    Author Photo

    With the New York Responsible AI Safety and Education Act taking effect March 19, state regulators will expect subject artificial intelligence governance policies to understand whether appropriate safeguards and protocols are in place to prevent or mitigate discriminatory or adverse outcomes by frontier models, says Michael Paulino at Gordon Rees.

  • What We Know About DOJ's New FCA Enforcement Priorities

    Author Photo

    Recent remarks from the leader of the Justice Department’s commercial litigation branch provide key insights on how False Claims Act cases — especially healthcare fraud, trade fraud, antidiscrimination and cybersecurity claims — will be evaluated, prioritized and pursued as heightened enforcement becomes the new normal, say attorneys at Latham.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • How PBMs Can Adapt To Plan Sponsors' Disclosure Demands

    Author Photo

    As federal reforms, growing state regulation and litigation threats push plan sponsors to expect visibility into revenue streams, pharmacy benefit managers should leverage transparency strategically, including by simplifying how they get paid, offering clients audit-ready data and co-designing contracts that are easy for fiduciaries to explain and defend, says Kristie Blase at Frazer + Blase.

  • How To Engage With Gov't's Direct-To-Consumer Drug Policy

    Author Photo

    The U.S. Department of Health and Human Services' recent request for industry input on manufacturers' direct-to-consumer drug sales reflects the government's caution in this arena, and allows stakeholders a rare opportunity to help shape policy, says Mary Kohler at Kohler Health Law.

  • Opinion

    It's Time To Clarify California's Elder Abuse Act

    Author Photo

    As California's elderly population soars, the Golden State's high court and Legislature must provide needed clarification about the scope of the Elder Abuse Act, to resolve the inconsistencies and ambiguities that have impeded the law's ability to remedy elder abuse, neglect and abandonment, say attorneys at Horvitz & Levy.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • When Fraud Involvement Disqualifies FCA Whistleblowers

    Author Photo

    A Massachusetts federal court's recent dismissal of a False Claims Act relator in U.S. ex rel. Perry v. First Psychiatric Planners provides instructive insight into when whistleblowers may be denied their share of settlement proceeds, even if their involvement in the underlying fraud is a step removed, say attorneys at Holland & Knight.

  • Job Shift Accommodation Ruling Clarifies 'Essential Function'

    Author Photo

    In Siebrecht v. Mercy Health-Iowa, the Eighth Circuit's recent denial of a disabled worker's shift exemption request shows that the essential function of a job can encompass more than core job requirements and include things like scheduling flexibility, says Kim Kirn at Miles Mediation & Arbitration.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • H-1B Registration Tips For New Wage-Weighted Selection

    Author Photo

    Practitioners participating in this year’s H-1B visa registration, currently underway, must understand that under the new wage-weighted selection process that replaced the random lottery, the crucial first step is choosing the correct standard occupational classification, says Jimmy Lai at Lai & Turner.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.